MARKET

VVOS

VVOS

Vivos Therapeutics, Inc.
NASDAQ

Real-time Quotes | Nasdaq Last Sale

3.120
-0.010
-0.32%
Closed 19:52 07/29 EDT
OPEN
3.180
PREV CLOSE
3.130
HIGH
3.270
LOW
3.060
VOLUME
199.28K
TURNOVER
--
52 WEEK HIGH
14.41
52 WEEK LOW
3.000
MARKET CAP
54.60M
P/E (TTM)
-4.7130
1D
5D
1M
3M
1Y
5Y
Vivos Therapeutics Opens State of the Art International Training Center In Denver
Vivos Therapeutics, Inc. (the "Company" or "Vivos") (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative diagnostic and treatment modalities for patients suffering from sleep-disordered breathing, including mild...
GlobeNewswire · 22h ago
CAN, DAO, NEGG among mid-day movers
Gainers: Bit Digital (BTBT) +51%.Infinity Pharmaceuticals (INFI) +46%.NanoVibronix (NAOV) +40%.Tilray (TLRY) +26%.Flora Growth Corp. (FLGC) +25%.Youdao (DAO) +24%.Grove (GRVI) +22%.Zhangmen Education (ZME) +23%.First High-School Education (FHS) +22%.Canaan...
Seekingalpha · 1d ago
Infinity Pharmaceuticals, Grove leads healthcare gainers; Dyadic, EyeGate Pharmaceuticals among major losers
Gainers: Infinity Pharmaceuticals (INFI) +62%, Grove (GRVI) +26%, Shineco (TYHT) +24%, Tilray (TLRY) +22%, NeuroMetrix (NURO) +19%.Losers: Dyadic (DYAI) -14%, EyeGate Pharmaceuticals (EYEG) -13%, NanoViricides (NNVC) -13%, Myovant Sciences (MYOV) -9%, Vivo...
Seekingalpha · 1d ago
The Daily Biotech Pulse: Moderna To Join S&P 500 Index, Thumbs Down For FibroGen's Anemia Drug, Corvus Shelves COVID Study
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 15)
Benzinga · 07/16 11:37
Vivos Therapeutics reports results of Class 1 DNA appliance in obstructive sleep apnea
Vivos Therapeutics ([[VVOS]] -0.4%) announces results from a national study to assess patients’ airway function and obstructive sleep apnea ((OSA)) symptoms after undergoing the Vivos treatment. In the study, 28% of
Seekingalpha · 07/13 15:12
BRIEF-One In Four Patients In Latest Clinical Study Show No Symptoms Of Obstructive Sleep Apnea After Vivos Treatment
reuters.com · 07/13 12:08
64 Biggest Movers From Friday
Gainers Sentage Holdings Inc. (NASDAQ: SNTG) shares surged 597.8% to settle at $34.89 on Friday as the company priced its IPO at $5 per share.
Benzinga · 07/12 09:16
38 Stocks Moving In Thursday's Mid-Day Session
Gainers Carver Bancorp, Inc. (NASDAQ: CARV) shares jumped 251.5% to $37.19 after gaining 8% on Wednesday.
Benzinga · 07/08 16:06
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of VVOS. Analyze the recent business situations of Vivos Therapeutics, Inc. through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 2 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average VVOS stock price target is 11.50 with a high estimate of 12.00 and a low estimate of 11.00.
EPS
Institutional Holdings
Institutions: 18
Institutional Holdings: 820.71K
% Owned: 4.69%
Shares Outstanding: 17.50M
TypeInstitutionsShares
Increased
1
48.00K
New
14
347.89K
Decreased
3
50.93K
Sold Out
6
254.13K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
No Data
No Data
About VVOS
Vivos Therapeutics, Inc. is a medical technology company. The Company is focused on the development and commercialization of a differentiated technology offering a clinically effective non-surgical, non-invasive and non-pharmaceutical for patients with sleep disordered breathing (SDB), including obstructive sleep apnea (OSA). It is engaged in the designing and selling of oral devices that assist with sleep and breathing disorders and hosting training seminars for medical and dental professionals on sleep and breathing disorders. The Company owns and operates three locations where Vivos systems are measured and fitted. The Company licenses its intellectual property to third-party manufacturers which fabricate appliance devices for orders requested by healthcare professionals, at a specified price per appliance.

Webull offers kinds of Vivos Therapeutics Inc stock information, including NASDAQ:VVOS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VVOS stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading VVOS stock methods without spending real money on the virtual paper trading platform.